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Microbiological point of care testing before
antibiotic prescribing in primary care:
considerable variations between practices
Steffen Haldrup1,2*, Reimar W. Thomsen1, Flemming Bro2, Robert Skov3, Lars Bjerrum4 and Mette Søgaard1*
Abstract
Background: Point-of-care testing (POCT) in primary care may improve rational antibiotic prescribing. We examined
use of POCT in Denmark, including patient- and general practitioner (GP)-related predictors.
Methods: We linked nationwide health care databases to assess POCT use (C-reactive protein (CRP), group A
streptococcal (GAS) antigen swabs, bacteriological cultures, and urine test strips) per 1,000 overall GP consultations,
2004–2013. We computed odds ratios (OR) of POCT in patients prescribed antibiotics according to patient and GP
age and sex, GP practice type, location, and workload.
Results: The overall use of POCT in Denmark increased by 45.8% during 2004–2013, from 147.2 per 1,000 overall
consultations to 214.8. CRP tests increased by 132%, bacteriological cultures by 101.7% while GAS swabs decreased
by 8.6%. POCT preceded 28% of antibiotic prescriptions in 2004 increasing to 44% in 2013. The use of POCT varied
more than 5-fold among individual practices, from 54.9 to 394.7 per 1,000 consultations in 2013. POCT use varied
substantially with patient age, and males were less likely to receive POCT than females (adjusted OR = 0.75, 95% CI
0.74-0.75) driven by usage of urine test strips among females (18% vs. 7%). Odds of POCT were higher among
female GPs and decreased with higher GP age, with lowest usage among male GPs >60 years. GP urban/rural
location and workload had little impact.
Conclusion: GPs use POCT increasingly with the highest use among young female GPs. In 2013, 44% of all
antibiotic prescriptions were preceded by POCT but testing rates vary greatly across individual GPs.
Keywords: Point-of-care, Antibiotic, Infection, General practice
Background
As much as 50% of antibiotic use in human medicine
may be either unnecessary or inappropriate across all
health care settings [1–3]. For instance, acute bronchitis
accounts for approximately 80% of lower respiratory
tract infections and despite guidelines, randomized
controlled trials, and meta-analyses showing little or no
benefit from antibiotics [4, 5], up to 80% of patients
consulting for this condition are prescribed antibiotics
[6–9].
In Denmark, general practitioners (GPs) account for
more than 80% of the total antibiotic use [10]. To reduce
ineffective and unnecessary antibiotics the Danish
National Board of Health in 2012 issued a guideline that
encourages rational antibiotic prescribing (i.e., use of
narrow spectrum antibiotics), and to only prescribe
antibiotics when necessary based on clinical and
microbiological examination [11]. Diagnostic uncertainty
increases the risk of unnecessary antibiotic prescribing
[6, 12], and a key to rational prescribing is to perform
point-of-care testing (POCT) [13]. POCT is defined as
medical diagnostic testing at or near the site of care [14],
and use of POCT such as enzyme immunoassay kits
(e.g., group A streptococcal (GAS) antigen), measure-
ment of C-reactive protein (CRP), urine test strips and
bacteriological cultures may reduce diagnostic uncertainty
[15–17] and thereby antibiotic prescribing [17–23]. Thus,
POCT may contribute to safely withholding antibiotics
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from patients who most probably would not benefit from
antibiotic treatment. Nonetheless, while there is a large
body of literature on prescribing patterns among GPs, few
studies have examined the use of POCT in relation to anti-
biotic prescribing [16, 23, 24]. Studies from Sweden and
Switzerland have shown that approximately 42% of patients
consulting a GP for an acute respiratory tract infection
receive a CRP-test [16, 25]. Older patients, those with
higher education, and those with more discomfort are more
likely to receive testing [16]. Another study showed that
physicians were less likely to perform streptococcal tests in
children with pharyngitis at the end of the week (Thursday
and Friday) (adjusted relative risk 0.75, 95% confidence
interval (CI) 0.66-0.87) compared with the first days of the
week [26]. In line with this, a US study showed that strepto-
coccal testing rates varied from 59% to 83% among
different health plans for children with pharyngitis who
were prescribed antibiotics [27]. Still, there is limited
population-based information on the prevalence and time
trends of use of POCT before antibiotic prescribing in
primary care and about what characterizes patients and
GPs who use POCT. Information on predictors of POCT
may help to identify interventions to improve the efficient
use of antibiotics. We therefore undertook a nationwide
population-based study to examine the use of POCT in
relation to antibiotic prescribing in the Danish primary
health care sector in 2004–2013, and investigated patient
and GP-related predictors for use of POCT.
Methods
Setting and study population
This population-based cross-sectional study was based
on the entire Danish population with approximately 5,5
million residents between 2004 and 2013. The Danish
healthcare system provides tax-supported health care to
all residents, guaranteeing free access to hospitals,
primary medical care, and partial reimbursement for
prescribed medications, including most antibiotics. A
unique central personal registration number, assigned to
all Danish residents at birth or upon immigration, is
used to record health care services in various nationwide
registries, allowing unambiguous linkage among
registries [28]. The current nationwide study is based on
information from the Danish National Health Insurance
Service Registry (DNHSR) [29], the Danish National
Health Service Prescription Database (DHSPD) [30], and
data provided by Danish Regions (www.regioner.dk).
POCT and antibiotic prescriptions
We obtained information on POCT and number of GP
consultations through the DNHSR. Except for 2% of the
population, all Danes are enlisted with a particular
general practice of their choice and all services provided
to this population are recorded through activity codes in
the DNHSR which contains data collected from health
contractors in primary care since 1990 [29]. The
DNHSR include information about patients (e.g., civil
registration (CRS) number, date of entering present
general practice, present and previous general practice
number), the general practices (including a unique
practice identification number which we used to ascer-
tain that only GPs were included, and practice type (sin-
gle-handed vs. partnership)), and health services (type of
consultation (ordinary, telephone, home visit, or email)
and any laboratory tests performed (including CRP
measurement, GAS antigen throat swabs, bacteriological
cultures, urine test strips and microscopy). Each labora-
tory test has a unique four-digit code and is a health
service for which the GP is compensated. We utilized
these four digit codes, along with the six digit practice
identification number, to identify all POCT performed
by GPs between 2004 and 2013.
We then obtained information on all filled antibiotic
prescriptions in Denmark during 2004–2013 through
the DHSPD [30]. This database records the patients’ per-
sonal identifier, date of dispensing, and the type and
quantity of drug prescribed (according to the Anatom-
ical Therapeutic Chemical (ATC) Classification System)
each time a prescription is redeemed at any Danish
pharmacy. For all antibiotic prescriptions, we ascertained
whether the patients had POCT performed within the
preceding 14 days of filling the antibiotic prescription.
Patient characteristics
We categorized patients according to sex, age (0–4, 5–9,
10–14, 15–19, 20–39, 40–64, 65–79, and ≥80 years), and
prescribed antibiotics categorized as; tetracycline (J01AA),
beta-lactamase sensitive penicillin (J01CE), penicillin with
extended spectrum (J01CA), beta-lactamase resistant
penicillin (J01CF), combinations of penicillin incl. beta-
lactamase inhibitors (J01CR), sulphonamide and
trimethoprim (J01E), macrolide, lincosamide and strep-
togamin (J01F), quinolone (J01MA), and other antibi-
otics (J01D, G, X).
GP characteristics
Through the DNHSR, we obtained data on the GP’s
annual number of ordinary consultations per 1,000 reg-
istered patients as proxy for GP workload (categorized
in quintiles as <5675, 5675–6354, 6355–7189, >7190)
[31], type of practice (single-handed versus partnership
practice), and geographical location of practice (health
care administrative region, city size (<5000 inhabitants
or ≥5000 inhabitants). For single-handed practices we
further obtained information about the GP’s age (<41,
41–50, 51–60, and ≥60 years) and sex from Danish
Regions. This information was not available for
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partnership practices because the six-digit practice iden-
tifier is applied to the practice and not the individual
GP. We restricted the study to GPs with at least 500 reg-
istered patients to reduce the impact by inactive GPs on
the observed variation.
Statistical analysis
We computed the annual prevalence of use of any
POCT and of specific tests per 1,000 overall consulta-
tions in general practice, and estimated the prevalence
proportion of antibiotic prescriptions preceded by
POCT. We truncated the data at the 1st and 99th per-
centiles due to ambiguous rates (outliers). To compare
the rates in different years and across different GPs, we
standardized the rates to the age- and sex distribution of
the population of Denmark as of January 1 2013
(obtained from statistics Denmark), using direct
standardization. Subsequently, we used logistic regres-
sion to compute crude and adjusted odds ratios (OR)
with 95% CIs for use of POCT prior to antibiotic
prescribing according to patient age and sex, practice
location (geographical region and city size) as well as the
GP’s age, sex and workload. The predictors were mutu-
ally adjusted. As the prevalence of pre-antibiotic POCT
changed over time, we restricted analyses of predictors
to 2013 in order to describe predictors of POCT in the
most recent year. Analyses of the impact of GP age and
sex were restricted to single-handed practices as this in-
formation was not available for partnership-practices.
Data management and statistical analysis was conducted
in SAS version 9.2/9.4 (SAS Institute, Cary, NC) and
STATA 14 (Stata Corp., College Station, TX, USA).
Results
From 2004 to 2013, 27,267,874 antibiotic prescriptions
were registered in the DHSPD. Of these, we excluded
5,496,924 prescriptions issued by other authorities than
GPs in the primary health care, for instance doctors
from the emergency service and specialists, and
1,608,012 prescriptions due to incomplete data, e.g.,
missing information about the issuing GP. Thus, the
study included 20,162,938 antibiotic prescriptions issued
by 2,021 practices to 4,434,916 patients. A total of 1,051
(52%) of the GPs worked in single-handed practices, and
970 (48%) constituted partnership practices. The usage
of POCT before antibiotic prescribing amounted to
7,344,586 tests.
Use of POCT according to type of prescribed antibiotics
In 2004, 28% of the antibiotic prescriptions were
preceded by POCT compared with 44% in 2013, corre-
sponding to a 45% increase in the use of POCT prior to
antibiotic prescribing (Fig. 1). The use of POCT
differed substantially by type of prescribed antibiotic.
For example, in 2013 the proportion of antibiotic
prescriptions preceded by POCT varied from 4% for
tetracycline to 44% for sulphonamide and trimethoprim
prescriptions (Fig. 2).
Fig. 1 Proportion of antibiotic prescriptions with and without a preceding microbiological point-of-care test (POCT) according to type of test
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Age and sex standardised rates of POCT per 1,000 overall
consultations
The overall age and sex standardised prevalence rate
of POCT was 147.2 per 1,000 consultations in 2004
and increased by 45.8% reaching 214.8 tests per
1,000 consultations in 2013. However, the use of in-
dividual POC tests differed markedly over time
(Fig. 3). With 53.0 tests per 1,000 consultations
urine test strips was by far the most frequently used
test in 2004 and the usage increased by 5.5% ending
at 55.9 per 1,000 consultations in 2013. Concur-
rently, CRP measurements increased by 132.0%
(from 30.7 per 1,000 to 71.3 per 1,000) and bacterio-
logical cultures by 101.7% (from 26.8 per 1,000 to
54.0 per 1,000). In 2013, CRP was the most fre-
quently used test before antibiotic prescribing. In
comparison, the use of GAS antigen swabs decreased
by 8.6%, from 36.8 per 1,000 consultations in 2004
to 33.6 in 2013.
Rates of POCT use among the 2045 GPs varied by
approximately a 5-fold, from 54.9 to 394.7 per 1,000
consultations in 2013 (median = 203, interquartile range
(IQR) = 167–241) and even more for the individual tests;
bacteriological cultures varied by more than 30-fold
from 4.1 to 123.8 per 1,000 consultations (median = 48,
IQR =32-67); urine test strips by almost a 12-fold from
11.6 to 121.3 per 1,000 (median =51, IQR =43-64); GAS
antigen tests by more than 38-fold from 2.5 to 94.8
(median = 31, IQR = 24–42) and CRP measurement from
0.00 to 183.2 per 1,000 consultations (median = 63, IQR
= 42–89).
Predictors of POCT use according to patient and GP
characteristics
Table 1 shows patient- and GP-related predictors of
POCT prior to antibiotic prescribing in 2013. The pro-
portion of patients with POCT varied from 33% in chil-
dren aged 0–4 years to 59% in teenagers aged 15–19
years, equivalent to an adjusted OR of 2.14 (95% CI
2.10-2.17). The usage of the specific tests varied greatly
by age, for example 31% of children aged 5–9 years were
tested for GAS antigen prior to antibiotic prescribing
compared with only 1% of patients aged 65–79 years,
whereas the use of urine test strips increased with age.
Use of bacteriological cultures and CRP measurement
also varied with age but less pronounced. Compared
with women, men were less likely to receive a POCT
(adjusted OR = 0.75, 95% CI 0.74-0.75). This difference
was primarily driven by higher usage of urine test strips
among females (18% in females vs. 7% in males), while
the use of other tests differed little by sex.
Use of POCT varied across health care regions. Com-
pared with patients living in the Capital Region of
Denmark, patients in the North Denmark Region were
more likely to receive POCT (adjusted OR = 1.19, 95%
CI 1.18-1.20), particularly due to a higher use of urine
test strips (16% vs. 12%) and CPR measurements (15%
vs. 10%). Patients in the Central Denmark Region
Fig. 2 Proportion of antibiotic prescriptions with and without a preceding microbiological point-of-care test (POCT) in 2013 according to type of
prescribed antibiotic
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(adjusted OR = 0.81, 95% CI 0.80–0.82) and Region
Zealand (adjusted OR = 0.91–0.92) were less likely to be
tested compared with patients in the Capital Region. In
contrast, there was no important rural–urban gradient,
i.e., use of POCT varied little by the size of the city
where the practice was located (Table 1).
Analyses restricted to GPs working in single-handed
practices showed that compared with young female GPs
(<41 years), female GPs aged 42–50 years were more
likely to use POCT (adjusted OR = 1.06, 95% CI 1.02–
1.11) while female GPs aged older than 60 years were
less likely (adjusted OR = 0.84, 95% CI 0.80–0.86). Male
GPs used less POCT compared with female GPs with
the odds of POCT decreasing with increasing age
(Table 1). The lowest use of POCT (except for use of
urine test strips) was observed for male GPs older than
60 years versus female GPs < 41 years (adjusted OR =
0.61, 95% CI 0.59-0.64). In particular, a larger proportion
of female GPs – except those older than 60 years – com-
pared with male GPs used urine test strips prior to pre-
scribing. Compared with GP age and sex, workload
appeared to have little impact on odds of POCT and
choice of specific tests (Table 1).
Discussion
This nationwide population-based cross-sectional study
covering a 10 year period and including more than 20
million antibiotic prescriptions issued by more than
2,000 Danish practices demonstrated an increasing use
of POCT before antibiotic prescribing in Denmark from
2004–2013. In 2013, GPs carried out POCT before 44%
of all antibiotic prescriptions. The pattern of POCT
shifted over time towards relatively higher rates of CRP
measurement in 2013. Nonetheless, there was wide vari-
ability in testing rates across GPs with a more than 5
fold inter-practice variation in the overall use of POCT
and considerably more for the individual tests. Odds of
POCT before antibiotic prescribing varied by patient age
and sex, and young female GPs were more likely to test
than older male GPs, whereas workload appeared to
have little influence.
Our study has strengths and weaknesses. We included
the entire Danish population through the use of nation-
wide registries and the study was conducted in a setting
in which the National Health Service provides unfettered
access to health care and partial reimbursement for pre-
scribed medications, thus largely eliminating referral and
diagnostic biases. The DNHSR holds detailed data on
the practices and the GPs and track changes during the
study period. The registry is used for reimbursement for
the GPs from the national health insurance and is con-
sidered to provide almost complete information. We do
not have estimates of the validity of the activities, but it
is generally considered to be high [29]. Notwithstanding,
we were unable to distinguish GP consultations during
ordinary working hours and out-of-hours GP service,
Fig. 3 Age- and sex standardized rates of microbiological point-of-care testing in individuals prescribed antibiotics and overall volume of prescribed
antibiotics in general practice, 2004–2013
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which is a main limitation of our study since these
entities may differ substantially in the propensity for
POCT. Moreover, we lacked data on GP age and sex
working in partnership-practices. In Denmark, antibi-
otics are available on prescription only and a very small
proportion is dispensed in hospitals. Since 2004, nation-
wide prescription data for antibiotic drugs have been as-
sessable through the DHSPD. However, this registry only
covers reimbursed medications and we likely underesti-
mated the volume of tetracycline and quinolones since
they were not reimbursed in 2013. According to national
statistics the volume of tetracycline prescribed in the
primary health care sector in 2013 amounted to 2.0
DDD per 1,000 inhabitants per day while the volume of
quinolones was only 0.5 DDD per 1,000 inhabitants per
day [32]. Another limitation of our study is that we do
not know the indications for POCT nor the result. We
used a 14-day time window to assess the use of POCT
prior to antibiotic prescribing, and, in theory, the test
could be unrelated to the actual antibiotic prescription.
Nonetheless, we consider these events to be part of the
same infectious episode. Moreover, as we only examined
use of POCT in patients prescribed antibiotics, we can-
not estimate to which extent use of POCT lead to non-
prescribing decisions. Finally, we did not have data on
practice staffing which may also influence POCT usage.
Limiting both over and under use of antibiotics in pri-
mary care is vital in reducing antibiotic resistance with-
out exposing patients to unnecessary risks. Some of the
high use of antibiotics in primary care may relate to
diagnostic uncertainty [6]. GPs may be under pressure
from patients who believe they need antibiotics [33].
With a negative test result at hand it may be easier for
the GP to refuse prescribing an unnecessary antibiotic
[15, 34, 35]. Thus, use of POCT to rule out a possible
bacterial infection may reduce diagnostic uncertainty
and increase confidence and acceptance of non-
prescription decisions [36]. In a Dutch RCT Cals et al.
[18] found that GPs assigned to CRP testing prescribed
fewer antibiotics compared with those who did not use
the test (31% vs. 53%). In line with this, other studies
have shown that use of POCT is associated with reduced
antibiotic prescribing [18, 22, 37–39] Importantly, a
recent Cochrane review concluded that this reduction in
antibiotic use in patients exposed to POCT is not
associated with differences in recovery or duration of
illness [38].
In Denmark, GPs have in-house lab facilities and
potentially have a financial incentive to carry out POCT,
because they are reimbursed by the National Health
Service for the use of these tests. Qualitative studies
have shown that GPs and patients generally report good
acceptability of POCT [35, 40, 41] and economic ana-
lyses show that POCT is cost-effective [42, 43].
Increased use of CRP measurements and bacteriological
cultures were the main drivers of the increased POCT,
whereas urine test remained stable and GAS antigen
swabs decreased. Compared with CRP measurements,
bacteriological cultures requires overnight incubation
and therefore cannot support “real-time” decisions. In
this respect, the increase in bacteriological cultures may
appear as a surprise. On the other hand, the increase
could reflect cultures taken following a positive CRP test
in order achieve a diagnosis and antimicrobial suscepti-
bility. We also observed wide variability in the use of
POCT across Denmark’s health care regions and in
particular by GP age and sex. Potential explanations for
the observed differences include a preference for female
GPs by young female patients and families with children.
It is also likely that older GPs feel more confident with
their clinical judgement, than younger GPs. Qualitative
research suggest that some GPs have concerns about
over reliance on test results, e.g., false positive results
that may lead to unnecessary antibiotic prescriptions as
well as false negatives leading to lack of necessary anti-
biotic treatment [35]. Interviews with 66 GPs who par-
ticipated in a RCT conducted in 6 European countries
revealed that the GPs felt that CRP testing was most
helpful in situations of uncertainty [44]. Thus, while
helpful, the GPs indicated that they would restrict the
use to cases of diagnostic uncertainty because of the
time taken to obtain a result [44]. They also expressed
concern that POCT could lead to more consultations in
future [44, 45]. In a Swedish study, 49% of all Strep-A
tests were performed in patients with a diagnosis of
common cold, sinusitis, acute bronchitis or pneumonia,
indicating that the tests were performed in patients with
a very low probability of GAS [46]. Likewise, another
Swedish study reported that 42% of all patients with a
diagnosis of respiratory infection were examined with a
CRP test [47]. The majority of these tests (69%) were
performed in patients with a diagnosis of upper respira-
tory infection. These findings indicate that the tests were
used too liberal and often not in a population with a
high probability of bacterial infection.
Conclusions
In conclusion, Danish GPs use POCT increasingly prior
to antibiotic prescribing. In particular, the use of CRP
measurement and bacteriological cultures increased
substantially while the use of strep-A tests decreased.
The proportion of patients tested and choice of test
varied greatly across GPs.
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